Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,323 papers from all fields of science
Search
Sign In
Create Free Account
Basal-Like Breast Carcinoma
Known as:
Basal-Like Breast Cancer
, Basal-Like Subtype of Breast Carcinoma
A biologic subset of breast carcinoma defined by high expression of genes characteristic of basal epithelial cells, including KRT5 and KRT17, annexin…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Breast
EGFR Protein Overexpression
EGFR gene
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Induction of N-Ras degradation by flunarizine-mediated autophagy
Ze-Yi Zheng
,
Jing Li
,
+5 authors
Y. Liao
Scientific Reports
2018
Corpus ID: 53563905
Ras GTPases are powerful drivers for tumorigenesis, but directly targeting Ras for treating cancer remains challenging. The…
Expand
2014
2014
Disrupting the Interaction of BRD 4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
Jian-Ting Shi
,
Yifan Wang
,
+16 authors
Binhua P. Zhou
2014
Corpus ID: 41563203
Jian Shi,1,4 Yifan Wang,1,4,5 Lei Zeng,6 Yadi Wu,2,4 Jiong Deng,7 Qiang Zhang,6 Yiwei Lin,1,4 Junlin Li,1,4 Tiebang Kang,5 Min…
Expand
2013
2013
Breast Cancer Subtypes and Previously Established Genetic Risk Factors: A Bayesian Approach
K. O’Brien
,
S. Cole
,
+4 authors
R. Millikan
Cancer Epidemiology, Biomarkers and Prevention
2013
Corpus ID: 6472468
Background: Gene expression analyses indicate that breast cancer is a heterogeneous disease with at least five immunohistologic…
Expand
2012
2012
Effect of anti-DR5 and chemotherapy on basal-like breast cancer
P. Oliver
,
A. Lobuglio
,
+7 authors
D. Buchsbaum
Breast Cancer Research and Treatment
2012
Corpus ID: 24956974
The purpose is to evaluate sensitivity of basal-like breast cancer to treatment with anti-DR5 alone and in combination with…
Expand
2010
2010
Is ALDH1 a good method for definition of breast cancer stem cells?
V. Neumeister
,
D. Rimm
Breast Cancer Research and Treatment
2010
Corpus ID: 30503799
Review
2010
Review
2010
Targeted chemotherapy? Platinum in BRCA1-dysfunctional breast cancer.
L. Carey
Journal of Clinical Oncology
2010
Corpus ID: 42883424
Although BRCA1-associated breast cancer is rare, comprising only 5% of breast cancers or fewer than 10,000 cases per year in the…
Expand
2009
2009
Potential Predictive Markers of Benefit from Cetuximab in Metastatic Breast Cancer: An Analysis of Two Randomized Phase 2 Trials.
L. Carey
,
J. O’Shaughnessy
,
+12 authors
C. Perou
2009
Corpus ID: 72327890
Background: Two randomized phase 2 studies investigated the efficacy of cetuximab (C), a mAb directed against EGFR, in metastatic…
Expand
Highly Cited
2008
Highly Cited
2008
GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
J. Rønneberg
,
J. Tost
,
+9 authors
V. Kristensen
Cancer Research
2008
Corpus ID: 11654113
The CpG island spanning the transcription start of the glutathione S-transferase P1 becomes methylated in a variety of human…
Expand
2008
2008
Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component.
P. Corsino
,
B. Davis
,
+4 authors
B. Law
Neoplasia
2008
Corpus ID: 37625828
The basal-like subtype of breast cancer is associated with invasiveness, high rates of postsurgical recurrence, and poor…
Expand
2007
2007
The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing…
Karen To
,
Yongjun Zhao
,
+12 authors
Sandra E. Dunn
Molecular Pharmacology
2007
Corpus ID: 11046979
The epidermal growth factor receptor (EGFR) is integral to basal-like and human epidermal growth factor receptor-2 (Her-2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE